Literature DB >> 35478412

NAFLD-related hepatocellular carcinoma: The growing challenge.

Pir Ahmad Shah1, Rashmee Patil2, Stephen A Harrison3.   

Abstract

Hepatocellular carcinoma (HCC) is a common cause of cancer-related mortality and morbidity worldwide. With the obesity pandemic, non-alcoholic fatty liver disease (NAFLD) related HCC is contributing to the burden of disease exponentially. Genetic predisposition and clinical risk factors for NAFLD-related HCC have been identified. Cirrhosis is a well-known and major risk factor for NAFLD-related HCC. However, the occurrence of NAFLD-related HCC in patients without cirrhosis is increasingly recognized and poses a significant challenge regarding cancer surveillance. It is of paramount importance to develop optimal risk stratification scores and models to identify subsets of the population at high risk so they can be enrolled in surveillance programs. In this review, we will discuss the risks and prediction models for NAFLD-related HCC. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2022        PMID: 35478412     DOI: 10.1002/hep.32542

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  3 in total

1.  The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma.

Authors:  Margaret L P Teng; Kai En Chan; Darren J H Tan; Daniel Q Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

2.  Prognostic Significance of CCDC137 Expression and Its Association with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Lu Bai; Zhao-Xu Yang; Jian-Shan Liu; De-Sheng Wang; Heng-Chao Yu
Journal:  Dis Markers       Date:  2022-08-24       Impact factor: 3.464

3.  Comparison of single‑nucleus and single‑cell transcriptomes in hepatocellular carcinoma tissue.

Authors:  Fei Wen; Xiaojie Tang; Lin Xu; Haixia Qu
Journal:  Mol Med Rep       Date:  2022-09-16       Impact factor: 3.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.